NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
Navy CTO on the Service’s AI-First Push
The service is focused on increasing speed and scale for software development and AI.
7m watch -
How Tech Advancements Support Military, Veteran Healthcare
The Department of Veterans Affairs and the Department of War are deploying a variety of technology-supported services to help warfighter and veterans behavioral health.
30m watch Partner Content -
Readiness Lessons From CIA's First Chief Wellbeing Officer
Former CIA Chief Wellbeing Officer Jennifer Posa discussed why workforce wellbeing is a strategic driver of mission success.
42m watch -
Air Force Software Official: AI Should Reuse Code, Not Rewrite It
CTO Kurt Jarvis explained how RAG, vector databases and DevSecOps guardrails help agencies safely integrate AI into coding.
7m watch
